Warfarin sensitivity-related gene polymorphism (SNPs) in Japanese pediatric patients

Warfarin sensitivity-related gene polymorphism (SNPs) in Japanese pediatric patients - Warfarin sensitivity-related gene polymorphism-SNPs-W

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020902

Enrollment

100

Registered

2016-02-10

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease, Kawasaki disease, myocardiac disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were treated with warfarin for 3 or more months, and have undergone PT-INR evaluation 3 times or more in this period

Exclusion criteria

Exclusion criteria: Patients who decline a written informed consent.

Design outcomes

Primary

Measure	Time frame
optimal warfarin dose and side effects	—

Countries

Japan

Contacts

Public ContactWakamiya Takuya

Yokohama City University School of Medicine Department of Pediatric Cardiology

baamiyan2000@yahoo.co.jp045-787-2800

Outcome results